Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study

I enjoy providing anesthesia for and taking care of a wide variety of complex patients in Duke University Hospital's main operating room and off site locations.  After finishing residency at The University of Pennsylvania, I worked in private practice outside Philadelphia and completed a fellowship in cardiothoracic anesthesia here at Duke, all of which prepared me for the variety of complex surgeries and patients we care for in the operating rooms here at Duke.  I also enjoy the research and education opportunities that come with working in this environment.  I have specifically worked on our enhanced recovery after surgery (ERAS) programs and am currently the Director of Liver Transplant Anesthesia.  I am engaged with a number of other operational roles including the Patient Safety and QI Committee, the Equipment Selection Committee and the Perioperative Leadership Group.

Dr. Michael W. Manning, MD, Ph.D., is an Associate Professor at Duke University Medical Center, within the Divisions of Cardiothoracic and General, Vascular, and Transplant anesthesia. He serves as the director of Enhanced Recovery after Surgery programs and the director of research for the Perioperative Medicine Fellowship at Duke. His clinical practice focuses on high-risk cardiac surgery, Heart, Lung, and Liver transplantation.

Dr. Manning earned a Ph.D. in cardiovascular physiology from the University of Kentucky, where he studied the role of Angiotensin II-mediated inflammation in the development of abdominal aortic aneurysms. After graduate school, Dr. Manning remained at the University of Kentucky, earning his MD degree. He completed a year of general surgery residency before switching to anesthesia. Following residency, Dr. 
Manning continued his clinical training at Duke University with a one-year clinical fellowship in Adult Cardiothoracic Anesthesiology and a 2-year research fellowship. He joined the Duke faculty in 2014. 

His current research interests are ERAS centered, specifically in the role of opioid-free anesthesia and goal-directed fluid therapy in cardiac surgery on renal outcomes.

Clinical and research interests are Enhanced Recovery and Perioperative Medicine; with particular interests in fluid management, and perioperative optimization of the high-risk non-cardiac surgery patient.